HPCAL1 and metabolic dysfunction-associated steatotic liver disease: Given that NAFLD is increasingly ranking the top risk factor for human liver cancer 54, dissecting the role and clinical relevance of HPCAL1 with NAFLD-associated HCC is of great significance for potential cancer subtyping and therapy.